Ono Venture Investment: Funding, Team & Investors | Startup Intros

Loading organizations...

Ono Venture Investment: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 1, 2025	Alchemab Therapeutics	$32.0M Series A	—	RA Capital, SV Health Investors, DCVC Bio, Mike Hutton, Lightstone Ventures, RA Capital Management, Kate Bingham
Jun 2, 2023	Violet Therapeutics	$10.6M Seed	Jonathan Behr, Atsushi Usami	Meredith Fisher, Shunichiro Matsumoto
Jun 1, 2023	Mozart Therapeutics	$25.0M Series A	ARCH Venture Partners, Soffinova Partners	Leaps by Bayer, MRL Ventures Fund, Takeda Ventures, Lucio Iannone, Jasmina Marjanovic, Alexandria Venture Investments, Altitude Life Science Ventures, Eli Lilly and Company, UPMC Enterprises
Mar 22, 2023	Curreio	$2.0M Series A	—	3S Capital, Asahi Kasei Pharma, Takehiko Sawabe, DOJIN Capital, IKERUNippon Capital Partners, Kamada, U-Tokyo Entrepreneur Supporter
Mar 1, 2023	Switch Therapeutics	$52.0M Series A	Insight Partners, Alicia Iruzun Lafitte	Alta Partners, Astellas Venture Management, Longwood Fund, Bold Capital Partners, Digitalis Ventures, Dolby Family Ventures, Eli Lilly and Company, Freeflow Ventures, PhiFund Ventures, Upfront Ventures
Nov 1, 2022	Casma Therapeutics	$46.0M Series C	—	Astellas Venture Management, The Column Group, Third Rock Ventures, Amgen Ventures, Hiromichi Kimura, Eisai, Euclidean Capital, Eventide Asset Management, Mirae Asset, Tomotaka Okino, Schroders Capital
Nov 9, 2021	Arbor Biotechnologies	$215.0M Series B	Frank Yu, Chen Yu, Temasek	ARCH Venture Partners, ArrowMark Partners, Deep Track Capital, GreatPoint Ventures, Illumina Ventures, Janus Henderson Investors, Logos Capital, Piper Heartland Healthcare Capital, Ridgeback Capital Investments, Section 32, Surveyor Capital, Tao Capital Partners, Tekla Capital Management, T. Rowe Price Associates, Vertex, Woodline Partners
Aug 1, 2021	Immunitas Therapeutics	$58.0M Series B	Agent Capital	Alta Partners, Cofounders Capital, Domain Associates, Leaps by Bayer, Longwood Fund, Novartis Venture Fund, Providence Ventures, RA Capital, Section 32, Netalie Nadivi, 120 Capital, Alexandria Venture Investments, Evotec, Brian Halak, Mirae Asset, M Ventures, Novartis, NS Investment, Solasta Ventures, The Leukemia & Lymphoma Society, The Mark Foundation for Cancer Research